ADCT
ADC Therapeutics SA
NYSE: ADCT · HEALTHCARE · BIOTECHNOLOGY
$3.78
+0.27% today
Updated 2026-04-29
Market cap
$480.78M
P/E ratio
—
P/S ratio
5.91x
EPS (TTM)
$-1.12
Dividend yield
—
52W range
$1 – $5
Volume
0.9M
ADC Therapeutics SA (ADCT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.80M | $1.14M | $2.34M | $0.00 | $33.92M | $209.91M | $69.56M | $70.84M | $81.36M |
| Revenue growth (YoY) | — | -36.8% | +105.3% | -100.0% | — | +518.9% | -66.9% | +1.8% | +14.9% |
| Cost of revenue | $85.53M | $118.09M | $107.54M | $141.82M | $1.39M | $3.30M | $2.53M | $5.95M | $7.67M |
| Gross profit | $-83.73M | $-116.95M | $2.34M | $-141.82M | $32.52M | $206.61M | $67.03M | $64.89M | $73.68M |
| Gross margin | -4643.8% | -10258.4% | 100.0% | — | 95.9% | 98.4% | 96.4% | 91.6% | 90.6% |
| R&D | $85.53M | $118.31M | $107.54M | $142.03M | $158.00M | $186.46M | $127.13M | $109.63M | $104.00M |
| SG&A | $7.81M | $8.60M | $14.20M | $55.13M | $71.46M | $107.74M | $72.88M | $64.47M | $36.56M |
| Operating income | $-91.67M | $-125.94M | $-119.40M | $-219.26M | $-261.72M | $-123.34M | $-165.99M | $-130.65M | $-108.38M |
| Operating margin | -5084.3% | -11047.5% | -5102.5% | — | -771.6% | -58.8% | -238.6% | -184.4% | -133.2% |
| EBITDA | $-91.33M | $-122.36M | $-114.10M | $-218.23M | $-230.53M | $-107.70M | $-145.83M | $-102.65M | $-106.50M |
| EBITDA margin | -5065.4% | -10733.2% | -4876.1% | — | -679.7% | -51.3% | -209.6% | -144.9% | -130.9% |
| EBIT | $-91.67M | $-122.87M | $-115.75M | $-219.05M | $-233.16M | $-110.09M | $-149.09M | $-105.92M | $-108.38M |
| Interest expense | $2.68M | $3.28M | $156000.00 | $4.93M | $18.34M | $36.73M | $46.33M | $50.21M | $51.63M |
| Income tax | $48000.00 | $224000.00 | $582000.00 | $327000.00 | $-21.48M | $227000.00 | $39.11M | $166000.00 | — |
| Effective tax rate | -0.1% | -0.2% | -0.5% | -0.1% | 8.5% | -0.1% | -19.5% | -0.1% | 0.0% |
| Net income | $-89.86M | $-123.10M | $-116.48M | $-246.29M | $-230.03M | $-157.13M | $-240.05M | $-157.85M | $-142.62M |
| Net income growth (YoY) | — | -37.0% | +5.4% | -111.4% | +6.6% | +31.7% | -52.8% | +34.2% | +9.6% |
| Profit margin | -4984.0% | -10797.9% | -4977.9% | — | -678.2% | -74.9% | -345.1% | -222.8% | -175.3% |